Physician profile
Andrew Straszewski
NPI 1417441916
$14,966.52
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $15.03 · 2021: $361 · 2022: $1,387 · 2023: $11K · 2024: $1,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $1,705 · Travel and Lodging: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $1,705.28 |
| Travel and Lodging | $1,093.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $10,191.22 | 2023-2024 | Acumed, Innate Implant |
| Stryker Corporation | $1,904.05 | 2019-2023 | T2 |
| Axogen | $1,373.15 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Medartis INC. | $479.89 | 2023 | Aptus |
| Medical Device Business Services, INC. | $220.00 | 2022 | |
| Depuy Synthes Sales INC. | $201.15 | 2021-2024 | Na |
| Checkpoint Surgical, INC | $146.12 | 2023 | Checkpoint Stimulators |
| Smith+Nephew, INC. | $144.61 | 2024 | Evos, Hat-Trick |
| Skeletal Dynamics INC | $132.32 | 2024 | Geminus, Ijs, Implate |
| Biocircuit Technologies INC | $103.63 | 2024 | |
| Orthopediatrics Corp. | $55.45 | 2022 | |
| Kci USA, INC. | $14.93 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Straszewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.